Inactive Instrument

News Kadmon Holdings, Inc.

Stocks

KDMN

US48283N1063

Pharmaceuticals

All News

21-11-10	Kadmon Holdings, Inc.(NasdaqGS:KDMN) dropped from S&P Global BMI Index	CI
21-11-10	Kadmon Holdings, Inc.(NasdaqGS:KDMN) dropped from S&P TMI Index	CI
21-11-10	Kadmon Holdings, Inc.(NasdaqGS:KDMN) dropped from S&P Biotechnology Select Industry Index	CI
21-11-09	Sanofi completes acquisition of Kadmon - Form 8-K	PU
21-11-09	KADMON HOLDINGS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendme (form 8-K)	AQ
21-11-09	Kadmon Holdings, Inc.(NasdaqGS:KDMN) dropped from NASDAQ Composite Index	CI
21-11-08	Sanofi completed the acquisition of Kadmon Holdings, Inc..	CI
21-11-08	Kadmon Holdings, Inc.(NasdaqGS:KDMN) dropped from NASDAQ Biotechnology Index	CI
21-11-05	KADMON HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
21-11-04	Kadmon Provides Business Update and Reports Third Quarter 2021 Financial Results	PU
21-11-04	KADMON HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
21-11-04	Kadmon Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI
21-11-04	Kadmon Provides Business Update and Reports Third Quarter 2021 Financial Results - Form 8-K	PU
21-11-04	Earnings Flash (KDMN) KADMON HOLDINGS Reports Q3 Revenue $14.7M	MT
21-10-28	KADMON HOLDINGS, INC. : Other Events (form 8-K)	AQ
21-10-21	Kadmon : Health Care Stocks Edging Higher At Close	MT
21-10-21	Kadmon : Announces Expiration of HSR Waiting Period in Sanofi Deal	MT
21-10-21	KADMON HOLDINGS, INC. : Other Events (form 8-K)	AQ
21-10-01	Kadmon : Announces Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer's 36th Annual Meeting	PU
21-09-14	KADMON : Mizuho Securities Downgrades Kadmon Holdings to Neutral from Buy, Adjusts Price Target to $9.50 from $13	MT
21-09-10	KADMON HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kadmon Holdings, Inc. - KDMN	BU
21-09-10	KADMON : UBS Downgrades Kadmon Holdings to Neutral From Buy, Adjusts PT to $9.50 From $9	MT
21-09-09	KADMON : Oppenheimer Suspends Rating for Kadmon Holdings Following Sanofi Merger	MT
21-09-09	KADMON : Jefferies Downgrades Kadmon Holdings to Hold from Buy, Adjusts Price Target to $9.50 from $10	MT
21-09-08	Kadmon Shares Rise 72% After Sanofi Bid of $9.50 a Share	DJ